This presentation provides an overview and summary of Johnson & Johnson's 2008 business performance and outlook for 2009. Key points include:
- J&J delivered sales growth of 4.3% in 2008 and exceeded earnings guidance. All three business segments - pharmaceutical, medical devices & diagnostics, and consumer - experienced sales growth.
- The presentation identifies growth drivers and pipeline advancements across J&J's businesses. It also addresses challenges from the economic environment and strategies to manage pressures in 2009.
- Looking forward, J&J will focus on growing existing businesses, building new platforms, and participating in healthcare policy to position itself for long-term leadership in an evolving industry.
For my Media Planning class, my team created a Media Plan for JetBlue. Our team's agency, Momentum Marketing, wanted to build top-of-the-mind awareness and to differentiate the JetBlue brand. Our big idea was to leverage JetBlue's cheap flights, deluxe legroom and in-flight entertainment to assure consumers that they can spend more money on their vacations and not their flights getting there.
GE Marketing Analysis
Discussion points: GE's B-to-B marketing strategy
answer to study case Marketing Excellence: GE, Marketing Management, 15th Edition, Kotler Keller, Connecting with Customers
For my Media Planning class, my team created a Media Plan for JetBlue. Our team's agency, Momentum Marketing, wanted to build top-of-the-mind awareness and to differentiate the JetBlue brand. Our big idea was to leverage JetBlue's cheap flights, deluxe legroom and in-flight entertainment to assure consumers that they can spend more money on their vacations and not their flights getting there.
GE Marketing Analysis
Discussion points: GE's B-to-B marketing strategy
answer to study case Marketing Excellence: GE, Marketing Management, 15th Edition, Kotler Keller, Connecting with Customers
This presentation helps to identify the market interpretation of BIG 4 Auditing Giants. Everything is detailly well explained. It includes Market share capital, Labour, Turnover, Internship details etc! It will be much useful for MBA finance students.
Jet Blue Airway: Case Analysis (Strategic Audit)Anna Osmanay
The presentation analyses a case of Jet Blue Airway. Jet Blue Airway is an airline company that operates in the United States. Background information about the company as well as a strategic audit of the company is presented. The strategic audit has to do with the internal and external analysis of the environment of the company.
This presentation helps to identify the market interpretation of BIG 4 Auditing Giants. Everything is detailly well explained. It includes Market share capital, Labour, Turnover, Internship details etc! It will be much useful for MBA finance students.
Jet Blue Airway: Case Analysis (Strategic Audit)Anna Osmanay
The presentation analyses a case of Jet Blue Airway. Jet Blue Airway is an airline company that operates in the United States. Background information about the company as well as a strategic audit of the company is presented. The strategic audit has to do with the internal and external analysis of the environment of the company.
iHT² Health IT Summit New York - Mark MacNaughton, SVP & CIO, Medial Segment at Cardinal Health - Keynote Presentation “Information as an Asset - Moving From the T Side of IT to the I”
Designing a Better Planet with Big Data and Sensor Networks (for Intelligent ...Rainer Sternfeld
Planet OS is a data discovery engine designed for real world sensor data. One interface to access your local, remote, open and vendor data.
This presentation answers questions like:
• How is the growth of sensor data challenging traditional data management, storage and usability of it?
• What are the trends in machine data and how will sensor data change Big Data over the next decade?
• How many devices are there on the Internet today? What will happen to this map in 10 years?
• What is the sensor data value chain, what gives you competitive advantage over others?
• Why is sensor data hard?
• Examples and use cases of the markets utilizing the latest robotic and mobile sensing platforms on land (energy production, agriculture, connected cars, weather forecasting), in the ocean (oil & gas, marine acoustics, shipping, environmental monitoring), air (drones) and space (nanosatellites, data-driven weather forecasting).
• How Planet OS is solving these challenges with it's Data Discovery Engine and a mission to index the real world? What are the data types we work with? What are the applications and how having a single interface and a single index help organizations to increase their ROI of operations, emergency response and planning?
• The Industrial Internet (GE), The Internet of Everything (Cisco)
• Why Big Data clouds need trust management for secure operations over open networks? (Intertrust)
Lessons for successfully executing digital transformation in HealthcareHenk Bakker
Many common perceptions about digital transformation are
actually myths. Fortunately, our global survey of nearly 400 large firms, supplemented by 157 in-depth interviews
with senior executives in more than 50 large companies, provides factbased answers.
By: Karsten Russell-Wood, Philips Hospital to Home
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
A look at the key trends and challenges in applying Big Data to transform healthcare by supporting research, self care, providers and building ecosystems. Purchase the report here: https://gumroad.com/l/PlXP
mHealth Israel_Becton Dickinson_US Healthcare Digital Transformation_July 2015Levi Shapiro
Presentation for mHealth Israel by David Fegygin, VP of Health IT Integration and Strategic Innovation, Becton Dickinson, for mHealth Israel, July 14, 2015 in Tel Aviv
Staying Relevant in a High Volume, Commoditized, Medical Device Product Line ...marcus evans Network
Beth Krenzer, Cardinal Health - Speaker at the marcus evans Medical Device Manufacturing Summit Spring 2012, held in Las Vegas, NV, delivered his presentation entitled Staying Relevant in a High Volume, Commoditized, Medical Device Product Line in Manufacturing (Insourced and Outsourced)
Turin Startup Ecosystem 2024 - Ricerca sulle Startup e il Sistema dell'Innov...Quotidiano Piemontese
Turin Startup Ecosystem 2024
Una ricerca de il Club degli Investitori, in collaborazione con ToTeM Torino Tech Map e con il supporto della ESCP Business School e di Growth Capital
how can I sell my pi coins for cash in a pi APPDOT TECH
You can't sell your pi coins in the pi network app. because it is not listed yet on any exchange.
The only way you can sell is by trading your pi coins with an investor (a person looking forward to hold massive amounts of pi coins before mainnet launch) .
You don't need to meet the investor directly all the trades are done with a pi vendor/merchant (a person that buys the pi coins from miners and resell it to investors)
I Will leave The telegram contact of my personal pi vendor, if you are finding a legitimate one.
@Pi_vendor_247
#pi network
#pi coins
#money
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
how to sell pi coins at high rate quickly.DOT TECH
Where can I sell my pi coins at a high rate.
Pi is not launched yet on any exchange. But one can easily sell his or her pi coins to investors who want to hold pi till mainnet launch.
This means crypto whales want to hold pi. And you can get a good rate for selling pi to them. I will leave the telegram contact of my personal pi vendor below.
A vendor is someone who buys from a miner and resell it to a holder or crypto whale.
Here is the telegram contact of my vendor:
@Pi_vendor_247
NO1 Uk Divorce problem uk all amil baba in karachi,lahore,pakistan talaq ka m...Amil Baba Dawood bangali
Contact with Dawood Bhai Just call on +92322-6382012 and we'll help you. We'll solve all your problems within 12 to 24 hours and with 101% guarantee and with astrology systematic. If you want to take any personal or professional advice then also you can call us on +92322-6382012 , ONLINE LOVE PROBLEM & Other all types of Daily Life Problem's.Then CALL or WHATSAPP us on +92322-6382012 and Get all these problems solutions here by Amil Baba DAWOOD BANGALI
#vashikaranspecialist #astrologer #palmistry #amliyaat #taweez #manpasandshadi #horoscope #spiritual #lovelife #lovespell #marriagespell#aamilbabainpakistan #amilbabainkarachi #powerfullblackmagicspell #kalajadumantarspecialist #realamilbaba #AmilbabainPakistan #astrologerincanada #astrologerindubai #lovespellsmaster #kalajaduspecialist #lovespellsthatwork #aamilbabainlahore#blackmagicformarriage #aamilbaba #kalajadu #kalailam #taweez #wazifaexpert #jadumantar #vashikaranspecialist #astrologer #palmistry #amliyaat #taweez #manpasandshadi #horoscope #spiritual #lovelife #lovespell #marriagespell#aamilbabainpakistan #amilbabainkarachi #powerfullblackmagicspell #kalajadumantarspecialist #realamilbaba #AmilbabainPakistan #astrologerincanada #astrologerindubai #lovespellsmaster #kalajaduspecialist #lovespellsthatwork #aamilbabainlahore #blackmagicforlove #blackmagicformarriage #aamilbaba #kalajadu #kalailam #taweez #wazifaexpert #jadumantar #vashikaranspecialist #astrologer #palmistry #amliyaat #taweez #manpasandshadi #horoscope #spiritual #lovelife #lovespell #marriagespell#aamilbabainpakistan #amilbabainkarachi #powerfullblackmagicspell #kalajadumantarspecialist #realamilbaba #AmilbabainPakistan #astrologerincanada #astrologerindubai #lovespellsmaster #kalajaduspecialist #lovespellsthatwork #aamilbabainlahore #Amilbabainuk #amilbabainspain #amilbabaindubai #Amilbabainnorway #amilbabainkrachi #amilbabainlahore #amilbabaingujranwalan #amilbabainislamabad
how to sell pi coins on Bitmart crypto exchangeDOT TECH
Yes. Pi network coins can be exchanged but not on bitmart exchange. Because pi network is still in the enclosed mainnet. The only way pioneers are able to trade pi coins is by reselling the pi coins to pi verified merchants.
A verified merchant is someone who buys pi network coins and resell it to exchanges looking forward to hold till mainnet launch.
I will leave the telegram contact of my personal pi merchant to trade with.
@Pi_vendor_247
Poonawalla Fincorp and IndusInd Bank Introduce New Co-Branded Credit Cardnickysharmasucks
The unveiling of the IndusInd Bank Poonawalla Fincorp eLITE RuPay Platinum Credit Card marks a notable milestone in the Indian financial landscape, showcasing a successful partnership between two leading institutions, Poonawalla Fincorp and IndusInd Bank. This co-branded credit card not only offers users a plethora of benefits but also reflects a commitment to innovation and adaptation. With a focus on providing value-driven and customer-centric solutions, this launch represents more than just a new product—it signifies a step towards redefining the banking experience for millions. Promising convenience, rewards, and a touch of luxury in everyday financial transactions, this collaboration aims to cater to the evolving needs of customers and set new standards in the industry.
USDA Loans in California: A Comprehensive Overview.pptxmarketing367770
USDA Loans in California: A Comprehensive Overview
If you're dreaming of owning a home in California's rural or suburban areas, a USDA loan might be the perfect solution. The U.S. Department of Agriculture (USDA) offers these loans to help low-to-moderate-income individuals and families achieve homeownership.
Key Features of USDA Loans:
Zero Down Payment: USDA loans require no down payment, making homeownership more accessible.
Competitive Interest Rates: These loans often come with lower interest rates compared to conventional loans.
Flexible Credit Requirements: USDA loans have more lenient credit score requirements, helping those with less-than-perfect credit.
Guaranteed Loan Program: The USDA guarantees a portion of the loan, reducing risk for lenders and expanding borrowing options.
Eligibility Criteria:
Location: The property must be located in a USDA-designated rural or suburban area. Many areas in California qualify.
Income Limits: Applicants must meet income guidelines, which vary by region and household size.
Primary Residence: The home must be used as the borrower's primary residence.
Application Process:
Find a USDA-Approved Lender: Not all lenders offer USDA loans, so it's essential to choose one approved by the USDA.
Pre-Qualification: Determine your eligibility and the amount you can borrow.
Property Search: Look for properties in eligible rural or suburban areas.
Loan Application: Submit your application, including financial and personal information.
Processing and Approval: The lender and USDA will review your application. If approved, you can proceed to closing.
USDA loans are an excellent option for those looking to buy a home in California's rural and suburban areas. With no down payment and flexible requirements, these loans make homeownership more attainable for many families. Explore your eligibility today and take the first step toward owning your dream home.
what is the future of Pi Network currency.DOT TECH
The future of the Pi cryptocurrency is uncertain, and its success will depend on several factors. Pi is a relatively new cryptocurrency that aims to be user-friendly and accessible to a wide audience. Here are a few key considerations for its future:
Message: @Pi_vendor_247 on telegram if u want to sell PI COINS.
1. Mainnet Launch: As of my last knowledge update in January 2022, Pi was still in the testnet phase. Its success will depend on a successful transition to a mainnet, where actual transactions can take place.
2. User Adoption: Pi's success will be closely tied to user adoption. The more users who join the network and actively participate, the stronger the ecosystem can become.
3. Utility and Use Cases: For a cryptocurrency to thrive, it must offer utility and practical use cases. The Pi team has talked about various applications, including peer-to-peer transactions, smart contracts, and more. The development and implementation of these features will be essential.
4. Regulatory Environment: The regulatory environment for cryptocurrencies is evolving globally. How Pi navigates and complies with regulations in various jurisdictions will significantly impact its future.
5. Technology Development: The Pi network must continue to develop and improve its technology, security, and scalability to compete with established cryptocurrencies.
6. Community Engagement: The Pi community plays a critical role in its future. Engaged users can help build trust and grow the network.
7. Monetization and Sustainability: The Pi team's monetization strategy, such as fees, partnerships, or other revenue sources, will affect its long-term sustainability.
It's essential to approach Pi or any new cryptocurrency with caution and conduct due diligence. Cryptocurrency investments involve risks, and potential rewards can be uncertain. The success and future of Pi will depend on the collective efforts of its team, community, and the broader cryptocurrency market dynamics. It's advisable to stay updated on Pi's development and follow any updates from the official Pi Network website or announcements from the team.
Latino Buying Power - May 2024 Presentation for Latino CaucusDanay Escanaverino
Unlock the potential of Latino Buying Power with this in-depth SlideShare presentation. Explore how the Latino consumer market is transforming the American economy, driven by their significant buying power, entrepreneurial contributions, and growing influence across various sectors.
**Key Sections Covered:**
1. **Economic Impact:** Understand the profound economic impact of Latino consumers on the U.S. economy. Discover how their increasing purchasing power is fueling growth in key industries and contributing to national economic prosperity.
2. **Buying Power:** Dive into detailed analyses of Latino buying power, including its growth trends, key drivers, and projections for the future. Learn how this influential group’s spending habits are shaping market dynamics and creating opportunities for businesses.
3. **Entrepreneurial Contributions:** Explore the entrepreneurial spirit within the Latino community. Examine how Latino-owned businesses are thriving and contributing to job creation, innovation, and economic diversification.
4. **Workforce Statistics:** Gain insights into the role of Latino workers in the American labor market. Review statistics on employment rates, occupational distribution, and the economic contributions of Latino professionals across various industries.
5. **Media Consumption:** Understand the media consumption habits of Latino audiences. Discover their preferences for digital platforms, television, radio, and social media. Learn how these consumption patterns are influencing advertising strategies and media content.
6. **Education:** Examine the educational achievements and challenges within the Latino community. Review statistics on enrollment, graduation rates, and fields of study. Understand the implications of education on economic mobility and workforce readiness.
7. **Home Ownership:** Explore trends in Latino home ownership. Understand the factors driving home buying decisions, the challenges faced by Latino homeowners, and the impact of home ownership on community stability and economic growth.
This SlideShare provides valuable insights for marketers, business owners, policymakers, and anyone interested in the economic influence of the Latino community. By understanding the various facets of Latino buying power, you can effectively engage with this dynamic and growing market segment.
Equip yourself with the knowledge to leverage Latino buying power, tap into their entrepreneurial spirit, and connect with their unique cultural and consumer preferences. Drive your business success by embracing the economic potential of Latino consumers.
**Keywords:** Latino buying power, economic impact, entrepreneurial contributions, workforce statistics, media consumption, education, home ownership, Latino market, Hispanic buying power, Latino purchasing power.
Resume
• Real GDP growth slowed down due to problems with access to electricity caused by the destruction of manoeuvrable electricity generation by Russian drones and missiles.
• Exports and imports continued growing due to better logistics through the Ukrainian sea corridor and road. Polish farmers and drivers stopped blocking borders at the end of April.
• In April, both the Tax and Customs Services over-executed the revenue plan. Moreover, the NBU transferred twice the planned profit to the budget.
• The European side approved the Ukraine Plan, which the government adopted to determine indicators for the Ukraine Facility. That approval will allow Ukraine to receive a EUR 1.9 bn loan from the EU in May. At the same time, the EU provided Ukraine with a EUR 1.5 bn loan in April, as the government fulfilled five indicators under the Ukraine Plan.
• The USA has finally approved an aid package for Ukraine, which includes USD 7.8 bn of budget support; however, the conditions and timing of the assistance are still unknown.
• As in March, annual consumer inflation amounted to 3.2% yoy in April.
• At the April monetary policy meeting, the NBU again reduced the key policy rate from 14.5% to 13.5% per annum.
• Over the past four weeks, the hryvnia exchange rate has stabilized in the UAH 39-40 per USD range.
What price will pi network be listed on exchangesDOT TECH
The rate at which pi will be listed is practically unknown. But due to speculations surrounding it the predicted rate is tends to be from 30$ — 50$.
So if you are interested in selling your pi network coins at a high rate tho. Or you can't wait till the mainnet launch in 2026. You can easily trade your pi coins with a merchant.
A merchant is someone who buys pi coins from miners and resell them to Investors looking forward to hold massive quantities till mainnet launch.
I will leave the telegram contact of my personal pi vendor to trade with.
@Pi_vendor_247
If you are looking for a pi coin investor. Then look no further because I have the right one he is a pi vendor (he buy and resell to whales in China). I met him on a crypto conference and ever since I and my friends have sold more than 10k pi coins to him And he bought all and still want more. I will drop his telegram handle below just send him a message.
@Pi_vendor_247
6. “Safe Harbor” Statement
This presentation may contain “forward-looking statements” as defined in the Private Securities
Litigation Reform Act of 1995. These statements are based on current expectations of future
events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize,
actual results could vary materially from the Company’s expectations and projections.
Risks and uncertainties include general industry conditions and competition; economic
conditions, such as interest rate and currency exchange rate fluctuations; technological advances
and patents attained by competitors; challenges inherent in new product development, including
obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws
and regulations; and trends toward health care cost containment.
A further list and description of these risks, uncertainties and other factors can be found in Exhibit
99 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2007.
Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov,
www.jnj.com or on request from the Company. The Company does not undertake to update any
forward-looking statements as a result of new information or future events or developments.
7. Note On Non-GAAP Financial Measures
These presentations may refer to certain non-GAAP
financial measures. These non-GAAP financial
measures should not be considered replacements
for GAAP results. A reconciliation of these non-GAAP
financial measures to the most directly comparable
GAAP financial measures can be found in the
Investor Relations section of the Company’s website at
www.jnj.com.
12. 2008 – Business Highlights
• Delivered financial commitments
• Strengthened core businesses, launched new products
and line extensions
• Advanced our pipelines
• Expanded growth platforms through licensing and acquisitions
• Realized major cost structure improvements
• PCH integration on track
• $10 Billion share repurchase near completion
13. Financial Highlights:
2008 vs. 2007
% Change
Total Company 2008 2007 Total Ops
Sales $63.7B $61.1B 4.3% 1.9%
Adjusted Earnings* $12.9B $12.1B 6.8%
Adjusted EPS* $4.55 $4.15 9.6%
Free Cash Flow** $12.2B $12.3B
*Non-GAAP measure; excludes IPR&D charges and other special items
**Non-GAAP financial measure: defined as operating cash flow less capital spending; estimated as of1/19/09
14. 2008 – From Guidance to Results
2008
Jan. 2008
Actual
Guidance
Operational Sales Increase 1%-2% 1.9%
Adjusted EPS* $4.39-$4.44 $4.55
*Non-GAAP measure; excludes IPR&D charges and other special items
15. 2008 Sales by Segment
Total Sales $63.7 Billion
Consumer
25%
$23.1B $16.0B
MD&D
36%
$24.6B
Pharmaceuticals
39%
19. Segment Operating Profit*
$17.3B
$15.9B
$2.7
$2.3
% to Sales
$7.0
2007 26.0% $6.0
2008 27.1%
$7.6 $7.6
2007 2008
*Non-GAAP
Pharm MD&D Consumer
measure; excludes IPR&D charges and other special items
20. Track Record of Performance
Exceptionally
Consistent
Performance
• 76 Consecutive years of Sales increases
• 25 Consecutive years of Adjusted Earnings increases*
• 46 Consecutive years of Dividend increases
*Non-GAAP measure; excludes IPR&D charges and other special items
21. History of Total Shareholder Return
as of 12/31/2008
Year 1 3 5 10
-7.8% 2.4% 5.4% 5.6%
S&P 500 -37.0% -8.4% -2.2% -1.4%
S&P Pharmaceutical -18.2% -0.3% -2.4% -2.3%
S&P H/C Equipment -27.6% -7.5% -2.2% 2.8%
Dow Jones Index -31.9% -4.1% -1.1% 1.7%
Note: Data source - Bloomberg
23. Where We Compete: Today and Future
2007 Split of Global Health Care Spend
100%= $4.1 Trillion
MD&D
6.0% Johnson & Johnson Presence
Consumer
12.0%
Other Health Care Markets
Pharm 67.5%
14.5%
Source: OECD; Espicom, Euromonitor (2008); HRI Global MD&D Report; CIA World Fact Book
24. Factors Influencing
2009 Business Performance
Health Care
Health Care
Environment
Environment
Business Near Term
Currency
Business Pressures
Results
Volatility
Macroeconomic
Environment
25. Forces Shaping the
Health Care Environment
• Aging population
• Consumer-driven health care
• Focus on wellness & prevention
• Rising prevalence of chronic disease
• Shifting trends in health care reform
• Pressure on health care budgets and systems
• Evolving health care delivery models
26. Factors Influencing
2009 Business Performance
Near Term
Business
Currency
Business Pressures
Results
Volatility
Macroeconomic
Environment
27. Addressing Near Term
Business Pressures
• Streamlined organization to reduce cost base
• Prioritized investments and focused on
key R&D priorities
• Continued to invest in new products
• Focused investments in emerging markets
• Expanded presence in new and adjacent markets
29. Potential Market Trends
• Slower growth trends in Rx market
• Cutback in health care treatments
• Postponement of some surgeries
• Tighter inventory levels and health care budgets
• Pressure on consumer spending
Source: IMS Data, Analyst Reports
31. Significant Currency Volatility
1.60
1.55
1.50
1.45
1.40
1.35
1.30
1.25
1.20
7/1/2008 7/31/2008 8/30/2008 9/29/2008 10/29/2008 11/28/2008 12/28/2008
EUR to USD Fx Rate
July 1, 2008 - Dec 31, 2008; interbank rate
32. Addressing Business
and Environmental Pressures
• Strong, experienced leaders in place
• Advancing pipeline and launching new products
• Building on market leadership positions
• Financial strength and flexibility
• Cost structure improvements
• Active participant in public policy dialogue
34. Strategic Framework
Our Credo
Operating Model
Broadly Based Managed Decentralized People
in Human for the Management and
Health Care Long Term Approach Values
Business Priorities
Accelerating Developing
Capitalizing Growth in
Winning in Leadership
on Emerging
Health Care and Talent
Convergence Markets
35. Winning in Health Care
Key Elements
• Growing our existing businesses
• Building new platforms for growth
• Participating in public policy dialogue
36. Winning in Health Care
Growth through R&D
$U.S. Billions
$7.7 $7.6
$7.1
$6.5
$5.3
$4.8
5-Year CAGR
9.4%
2003 2004 2005 2006 2007 2008
11.5% 11.9%
% to Sales
37. Advancing the Pharmaceutical Pipeline
NME Filings 2007-2010*
2007 2008 2009-2010
Approved Approved Planned Filings
Telaprevir (E.U.)
DORIBAX™ (doripenem) INTELENCE™ (TMC125)
Infectious Disease
Infectious Disease Infectious Disease
Tapentadol TMC 278
Pain Infectious Disease
DACOGEN™ (E.U.)
Filed Filed Oncology
Ceftobiprole** Golimumab (CNTO 148)
Infectious Disease Immunology
Filings assumed to be in U.S.
Paliperidone Palmitate** Rivaroxaban
unless otherwise noted
Central Nervous System Cardiovascular Disease
Ustekinumab (CNTO 1275)** Carisbamate
Immunology Central Nervous System
YONDELIS®
Dapoxetine (E.U.) As of 1/20/09
Reproductive Health Oncology
Carisbamate is licensed from SK-Bio Pharmaceuticals; Doripenem from Shionogi & Co.; Ceftobiprole from Basilea Pharmaceutica; Telaprevir from Vertex Pharmaceuticals Incorporated; Rivaroxaban from Bayer HealthCare; YONDELIS from PharmaMar; DACOGEN from Eisai Corporation of
North America; Tapentadol from Grunenthal GmbH; and Dapoxetine from PPD-GenuPro.;
*2009-2010 filings are anticipated filings
**Ceftobiprole has received a Complete Response from the FDA and a positive CHMP Opinion in the EU, Paliperidone Palmitate has received a Complete Response from the FDA and Ustekinumab has received a Complete Response from the FDA and a positive CHMP Opinion in the EU
38. Surgical Care Pipeline
Selective Highlights as of 1/20/09**
2007* 2008* 2009* 2010*
Approved*/Cleared*
Approved*/Cleared* Planned Submissions* Planned Submissions*
DePuy: TRILOCKTM Hip
DePuy: Sigma® CR150 mobile bearing
DePuy: GRIPTIONTM DePuy: Sigma® High Performance Instruments DePuy: CODMAN ENTERPRISE™
DePuy: LCS High Performance Instruments Vascular Reconstruction Device and
DePuy: Global AP Shoulder DePuy: Sigma PS150
DePuy: Sigma® High Performance Partial Knee
Delivery System
DePuy: Sigma CR150 Fixed Bearing
DePuy: Sigma CR Porocoat Femur DePuy: Hip Revision
DePuy: Sigma PS femur
Ethicon: GYNECARE GynOcclude
VERSALOKTM
DePuy: DePuy: ScoliScore (Alpha Launch)
DePuy: ALPS System Modules (Distal Tibia, Hand
Uterine Artery Occlusion (PMA)
Fracture System, Composite Fibula)
DePuy: ALPS System Modules (Small DePuy: Expedium LX
DePuy: CONFIDENCETM Spinal Cement System
and Large Fragment Sets) Ethicon: DERMABONDTM Topical
DePuy: HEALIXTM PEEK Suture Anchor System DePuy: ALPS System Modules (Anatomic
Skin Adhesive New Formulation
DePuy: Viper 2 MIS System
PRINEOTM
Ethicon: Skin Closure System Fibula, Anatomic Elbow, Proximal Tibia)
DePuy: MEDSTREAM™ Programmable Infusion System
(CE Mark) (CE Mark)
DePuy: Codman Neurovascular Orbit SR
(CE Mark)
Ethicon: EVITHROMTM Thrombin Topical
Ethicon: NUVANCE
Ethicon: EVICELTM Fibrin Human (Human)
(Human)
Ethicon: PROCEEDTM Ventral Patch Ethicon: Fibrin Pad (BLA)
Ethicon: UltraPROTM Hernia Plug Ethicon: GYNECARE PROLIFT +MTM Pelvic Floor Repair
Ethicon: GYNECARE GynOcclude Uterine
System
EES: EchelonTM 45
Artery Occlusion (CE Mark)
Ethicon: SYNSYLTM Synthetic Absorbable Suture (China)
EES: Harmonic SYNERGYTM Ethicon: MONOCRYL PlusTM Synthetic Absorbable Suture
Ethicon: PDS PlusTM Synthetic Absorbable
(CE Mark)
EES: Harmonic FOCUSTM Suture (CE Mark)
Ethicon: PROCEEDTM Ventral Patch (CE Mark)
Ethicon: Coated VICRYL* Plus Antibacterial (polyglactin
EES: REALIZETM Adjustable Gastric Band Ethicon: SURGIFLO with integrated thrombin
910) Suture (Japan)
Submitted* EES: Harmonic® Combination Hook
EES: Harmonic ACE ® Ergonomic
DePuy: Articular Surface Repair Hip
EES: EchelonTM Flex 45
(PMA)
EES: EchelonTM Flex 60
EES: REALIZETM Band C
DePuy: CERAMIC on CERAMIC Hip
(PMA)
Submitted*
DePuy: MEDSTREAM™ Programmable DePuy: AOX Polyethelene for Sigma and LCS * Filings/approvals assumed to be in U.S. unless otherwise noted.
Infusion System Ethicon: PRINEOTM Skin Closure System ** This information is accurate as of the date hereof to the best of the Company’s knowledge.
EES: SEDASYSTM System (PMA)
Johnson & Johnson assumes no obligation to update this information.
39. SEDASYS
First Personalized Sedation System
State-of-the-art Computer-controlled Simple and intuitive
patient monitoring drug delivery user interface
Investigational device: Limited by U.S. law to investigational use only
45. Science-Based
Innovation for Consumers
• Wide array of research competencies
• Significant portfolio of proprietary technologies
• Enhanced clinical trial expertise and global
R&D capabilities
46. Winning in Health Care
Market Leadership
Johnson & Johnson
#1 or #2
Lo-Cal Sweeteners
Anti-Anemia
Antipsychotics (Injectables) Blood Glucose Monitoring
Anti-TNF Blood Screening & Typing
Hormonal Contraceptives Electrophysiology Diagnostics & Catheters
Quinolone Anti-Infective Disposable Contact Lenses
Coronary Stents OTC Pharmaceuticals
Minimally Invasive Surgery
Sanitary Protection
Orthopaedics
Wound Care
Sutures
Baby & Kids Care
Psychostimulants
47. 2008 Product Launches & Extensions
• REALIZE Adjustable Gastric Band • INTELENCE
• CONFIDENCE Spinal Cement System • VELCADE
• TRI-LOCK Hip Stem with GRIPTION • PREZISTA
• SIGMA Knee Instruments • CONCERTA
• ZYRTEC
• New HARMONIC Energy Devices
• AVEENO Positively Ageless
• ONETOUCH PING
• LISTERINE Total Care
• ONETOUCH VITA
• ACUVUE Tru Eye
• ACUVUE OASYS for Astigmatism
49. New Growth Platforms
• Exploring white space opportunities outside
of existing businesses
• Established Wellness & Prevention platform
50. Public Policy Dialogue
• Active participation
• Unique perspective
• Diverse set of businesses
• Willingness to innovate
• Put needs of consumers and patients first
51. Strategic Framework
Our Credo
Operating Model
Broadly Based Managed Decentralized People
in Human for the Management and
Health Care Long Term Approach Values
Business Priorities
Accelerating Developing
Capitalizing Growth in
Winning in Leadership
on Emerging
Health Care and Talent
Convergence Markets
53. Capitalizing on Convergence
Convergence Opportunities
Power of
Patient-Centric
Convergent Products the Enterprise
Solutions
• NEVO Sirolimus • ZYRTEC launch
• Companion
Drug-Eluting Stent diagnostics
• Standardization
• Allergy medication • Johnson & Johnson
delivery via contact • Shared expertise
Diabetes Institute
lenses and proprietary
technology
• Personalized skin
• SEDASYS care
• Diverse capabilities
• Fibrin Pad and talent across
• Realize mySuccess
broad base
54. Strategic Framework
Our Credo
Operating Model
Broadly Based Managed Decentralized People
in Human for the Management and
Health Care Long Term Approach Values
Business Priorities
Accelerating Developing
Capitalizing Growth in
Winning in Leadership
on Emerging
Health Care and Talent
Convergence Markets
55. Accelerating Growth in Emerging Markets
Increases in Health Care Spending
Health Care Spending Per Capita CAGR 2008-13 (%)
20%
17%
14%
15%
12%
10%
10% 8%
6%
5%
4%
5%
2% 2%
1% 1% 1% 1%
0%
GermanyFrance Italy Spain UK Canada Brazil USA Mexico Japan Turkey Russia India China
Developed Countries Emerging Markets
Source: Espicom World Medical Factbook 2008
56. Accelerating Growth in Emerging Markets
Strengths in Emerging Markets
• Businesses in BRIC grew 19% operationally
• Significant, well-established presence
• Increased investment in local products and development
– Dabao acquisition
– Emerging Markets Innovation Center
• More than 20 professional education centers outside U.S.
57. Strategic Framework
Our Credo
Operating Model
Broadly Based Managed Decentralized People
in Human for the Management and
Health Care Long Term Approach Values
Business Priorities
Accelerating Developing
Capitalizing Growth in
Winning in Leadership
on Emerging
Health Care and Talent
Convergence Markets
58. Developing Leadership & Talent
Investing in Our People
• Developing leaders is a business priority
• More than 250 operating companies provide wide range of
leadership opportunities and challenges
• Decentralized management approach and structure fosters
entrepreneurial spirit and prudent risk-taking
Confidence in our future stems from
the talents of our people
59. Focused on Growth
• Participating in most attractive, fastest growing
segments of health care
• Building and sustaining leadership positions across
our business
• Growing sales faster than the markets, and growing
earnings faster than sales